News
The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.
4h
Asianet Newsable on MSNKarnataka heart attack report: 6 key causes of sudden deaths identified, says Minister Dinesh Gundu RaoKarnataka Health Minister Dinesh Gundu Rao released a report confirming no direct link between COVID-19 vaccines and sudden ...
The author says the action creates mistrust of the committee’s vaccine recommendations and further increases patients’ and ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But today, measles is roaring ...
We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best CRISPR stocks to buy. On June 23, H.C. Wainwright maintained its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results